<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>201</id><JournalTitle>RECENT ADVANCES IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE</JournalTitle><Abstract>Chronic obstructive pulmonary disease or COPD has been known to negatively affect people’s quality of life. It influences a
great number of individualities overall and is a main source of horribleness and mortality. It's associated with major
healthcare and socioeconomic burdens. So, it's important to cure similar types of conditions. There's a global increase in
frequence of this complaint but there are no medicines available at present that halt the grim progression of this complaint.
Still, a better understanding of the cellular and molecular mechanisms that are involved in the underpinning inflammatory
and destructive processes has revealed several new targets for which medicines are now in development, and the prospects
for chancing new treatments are good. This review article deals with the proper understanding of the recently developed
devices and varied advances taking place in the treatment of COPD. There are numerous new styles and procedures being
developed lately for the cure or treatment of COPD, of which some are mentioned in the following review composition. The
papers also deal with the salutary goods as well as the challenges faced during the use of those recently developed approaches
during the treatment of the disease. Varied types of devices of COPD similar as Inhalers – DPI (Dry powder inhalers), SMI
(Soft- mist inhalers), MDI (Metered dose inhalers) are also mentioned in the composition. This composition also deals with
the varied new advances that are presently taking place in devices used in the treatment of COPD</Abstract><Email>Susmitha@gmail.com</Email><articletype>Research</articletype><volume>14</volume><issue>2</issue><year>2024</year><keyword>Pulmonary diseases, Inhalers – DPI, SMI, MDI, Newer treatment of COPD.</keyword><AUTHORS>Susmitha J*, Dhayabaran D, Jeyaseeli Florance E, Sivaranjini M</AUTHORS><afflication>Dhanalakshmi Srinivasan Pharmacy and Research Institute, Coimbatore – 641 105, Tamil Nadu, India</afflication></Article></Articles>